2 min read

EverHint — High-Momentum Stock Picks (with Insider, Earnings & News Overlays) - October 30, 2025

October 30, 2025

What “breakout” means (quick)

A breakout is a decisive price move through prior resistance / near 52-week highs on above-normal volume, signaling demand broadening beyond recent ranges.

How we ranked today (reader version)

  1. Price/volume quality: proximity to 52-week highs, volume thrust ≥1.5×, short-term RS.
  2. Insiders: net open-market buys vs sells by ticker (dollar-weighted).
  3. News overlay: today’s company items add a small recency boost.
  4. Earnings timing: lighter if clear runway; near-dated prints flagged.
  5. Analyst cadence: count of recent estimate/notes updates.

Today’s Top Picks (ranked by EverHint composite)

Rank Ticker Company Last Near 52-W High Volume Thrust RS (21 d) Insider Net (USD) Days to Earnings Analyst Updates (30d)
1 VIAV Viavi Solutions Inc. 17.10 100% 5.23× 0 $0 90 36
2 FORM FormFactor, Inc. 59.25 100% 3.94× 1 $0 27
3 GH Guardant Health, Inc. 92.41 100% 4.43× 0 $0 12
4 INDV Indivior PLC 29.13 100% 6.04× 0 0 15
5 IMVT Immunovant, Inc. 24.82 100% 3.02× 0 $0 11 7
6 JAMF Jamf Holding Corp. 12.86 100% 3.63× 0 $0 11 8
7 FTAI FTAI Aviation Ltd. 186.76 100% 2.41× 0 15
8 CORZ Core Scientific, Inc. 20.74 100% 2.25× 0 7

Quick read

  • All eight names are pressing new-high zones with decisive volume; INDV and JAMF also sit near fresh catalysts (earnings/transactions).
  • Insider net in this cohort is neutral-to-light; no large open-market buys surfaced in today’s overlay.
  • Earnings runway flags: INDV (0 days) = today; IMVT (11) & JAMF (11) = near-dated.

Same-day headlines to watch (supports the tape)

  • VIAV — earnings & integration backdrop. Viavi reported FQ1’26 results yesterday amid the Spirent assets acquisition integration; strength aligns with fresh print + portfolio expansion. (investor.viavisolutions.com)
  • FORM — Q3 print just hit. FormFactor reported Q3’25 results on Oct 29 with webcast; breakout follows the print. (FormFactor Investors)
  • GH — raised 2025 revenue guidance. Guardant Health **reported Q3 and raised FY25 revenue guidance on Oct 29; momentum bid continues. (Guardant Health Investor Relations)
  • INDV — beat & guide up. Indivior Q3’25: revenue + guidance raised; program streamlining detailed today. (Indivior)
  • IMVT — event path set. Immunovant scheduled Nov 10 business update; eyes on FcRn pipeline cadence into that date. (Immunovant, Inc.)
  • JAMF — take-private. Jamf entered a definitive $2.2B take-private with Francisco Partners (Oct 29). (ir.jamf.com)
  • FTAI — Q3, dividend up, fundraising closed. FTAI reported Q3, raised dividend to $0.35, and closed $2.0B strategic vehicle fundraising this week. (ir.ftaiaviation.com)
  • CORZ — deal terminated. Core Scientific terminated its proposed CoreWeave merger after today’s vote; IR posted call details. (Core Scientific, Inc.)

On Watch (risk flags)

  • Catalyst-tight names: INDV (today); IMVT/JAMF (~11 days)gap risk around events/transactions.
  • Post-print digestion: FORM, VIAV, GH, FTAI — first sideways bases after the news pop often define cleaner risk.
  • News-driven names: JAMF, CORZ moves are event-dependent; control sizing.

Signals summary (today’s set)

  • Momentum: Leaders are at highs with 2.25×–6.04× volume thrust — broad participation, not just one-tick squeezes.
  • Insiders: Neutral overall — no outsized open-market buys to reinforce leadership today.
  • Earnings: Three near-dated; adjust entries/stop widths accordingly.
  • Analyst flow: Healthy update cadence in VIAV/FORM/FTAI buckets.

Vlad’s Take (EverHint)

Quality breakout tape with fundamental air cover (fresh results, guidance, or corporate events). Preference: scale-in on tight intraday pullbacks after the initial pop; use ATR-aware stops below the most recent higher-low. For catalyst-tight names (INDV/IMVT/JAMF), keep sizes smaller and let post-event ranges print before adding.


Independent, data-driven signals. No hype, no pumps, no paid promotions.